Massimo Piepoli

Massimo Piepoli's AcademicInfluence.com Rankings

Massimo Piepoli

Medical

#1755

World Rank

#2129

Historical Rank

Cardiology

#139

World Rank

#142

Historical Rank

medical Degrees

Massimo Piepoli

Philosophy

#5297

World Rank

#8057

Historical Rank

Logic

#2598

World Rank

#3610

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Massimo Piepoli's Degrees

PhD Cardiology University of Milan
Doctorate Medicine University of Milan

Why Is Massimo Piepoli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Massimo Piepoli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
ESC / EACTS Guidelines on myocardial revascularization (2012) (5643)
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (2013) (3723)
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous (2014) (3302)
Guidelines on myocardial revascularization. (2010) (2752)
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (2221)
ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014) (2085)
[2016 European Guidelines on cardiovascular disease prevention in clinical practice]. (2016) (1881)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016) (1844)
Guidelines on myocardial revascularization. (2010) (1272)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) (2004) (1021)
2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
2016 European Guidelines on cardiovascular disease prevention in clinical practice (2012) (904)
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2018) (811)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) (738)
Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation (2010) (728)
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation (2011) (612)
Expert position paper on air pollution and cardiovascular disease. (2015) (597)
Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. (1996) (550)
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. (2020) (532)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1997) (502)
213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (484)
Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry (2017) (475)
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (2019) (469)
Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey (2010) (444)
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. (2009) (414)
Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance: Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis (2001) (408)
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) (402)
Exercise training in patients with chronic heart failure (2004) (400)
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions (2016) (399)
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery (2014) (380)
Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. (2010) (367)
Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation (2009) (343)
Symptoms and quality of life in heart failure: the muscle hypothesis. (1994) (324)
Recommendations on pre‐hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine (2015) (323)
Tripling Survival From Sudden Cardiac Arrest Via Early Defibrillation Without Traditional Education in Cardiopulmonary Resuscitation (2002) (322)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2020) (310)
2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations (2018) (298)
Adherence of heart failure patients to exercise: barriers and possible solutions (2012) (283)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) (280)
Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure (2001) (278)
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry (2017) (278)
Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. (1997) (276)
Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts Survival (2006) (275)
Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart Disease (2008) (268)
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions (2017) (241)
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups* (2005) (241)
Muscle Ergoreceptor Overactivity Reflects Deterioration in Clinical Status and Cardiorespiratory Reflex Control in Chronic Heart Failure (2001) (240)
Effect of Aerobic Training on Walking Capacity and Maximal Exercise Tolerance in Patients With Multiple Sclerosis: A Randomized Crossover Controlled Study (2007) (235)
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020) (223)
2016 Focused Update: Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations (2016) (220)
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). (2000) (218)
Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity. (1999) (216)
Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group. (1998) (210)
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. (2006) (206)
Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. (2006) (205)
Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III) (2012) (197)
Quantitative General Theory for Periodic Breathing in Chronic Heart Failure and its Clinical Implications (2000) (196)
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2018) (191)
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia (2018) (183)
Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications. (2002) (181)
Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise. (1993) (179)
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology (2019) (172)
Predictors of exercise capacity in chronic heart failure. (1994) (169)
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC) (2020) (165)
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy (2019) (165)
Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy (2016) (165)
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. (2013) (164)
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. (2000) (158)
Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. (2001) (156)
Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar (2016) (156)
[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines]. (2016) (155)
Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology (2020) (155)
Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. (2003) (150)
Neural Regulation of Cardiovascular Response to Exercise: Role of Central Command and Peripheral Afferents (2014) (149)
Origin of respiratory sinus arrhythmia in conscious humans. An important role for arterial carotid baroreceptors. (1997) (149)
Reduced Peripheral Skeletal Muscle Mass and Abnormal Reflex Physiology in Chronic Heart Failure (2006) (148)
Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version. (2015) (144)
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (2017) (141)
ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (138)
A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure. (1999) (136)
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. (2016) (132)
Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and Americ (2015) (129)
Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and Americ (2015) (129)
The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology (2017) (129)
Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. (2006) (126)
Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis. (2019) (126)
Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology (2018) (125)
Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure. (1999) (122)
Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology* (2019) (122)
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. (2020) (121)
Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry (2019) (121)
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (121)
Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. (1997) (119)
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology (2020) (118)
In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry (2017) (118)
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020) (117)
Muscle metaboreceptors in hemodynamic, autonomic, and ventilatory responses to exercise in men. (1995) (116)
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure (2019) (114)
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2016) (113)
Contribution of skeletal muscle ‘ergoreceptors’ in the human leg to respiratory control in chronic heart failure (2000) (113)
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association (2018) (112)
Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology (2020) (108)
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II (2010) (107)
Heart Failure Association of the European Society of Cardiology position paper on frailty in patients with heart failure (2019) (106)
Impact of exercise‐based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta‐analysis of randomised trials (2018) (106)
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part I: Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure (2006) (105)
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. (2008) (104)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (103)
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I (2010) (102)
Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group (2018) (102)
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. (2009) (102)
Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training. (1995) (101)
Spectral analysis of heart rate variability in the sepsis syndrome (1993) (100)
Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits (2017) (99)
Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. (2007) (99)
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry. (2018) (98)
Overview of studies of exercise training in chronic heart failure: the need for a prospective randomized multicentre European trial. (1998) (95)
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study (2020) (95)
Global Impairment of Cardiac Autonomic Nervous Activity Late After Repair of Tetralogy of Fallot (2002) (94)
Physiological basis of fractal complexity properties of heart rate variability in man (2002) (92)
Muscle metaboreflex-induced increases in stroke volume. (2003) (92)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration (2014) (91)
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: How to perform cardiopulmonary exercise testing in chronic heart failure (2006) (91)
Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. (1992) (89)
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Recommendations for performance and interpretation (2006) (87)
Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and Americ (2015) (86)
Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry (2017) (86)
Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology (2020) (85)
Chronobiological patterns of onset of Tako-Tsubo cardiomyopathy: a multicenter Italian study. (2009) (84)
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST (2017) (83)
Skeletal muscle training in chronic heart failure. (2001) (83)
Global Impairment of Cardiac Autonomic Nervous Activity Late After the Fontan Operation (2003) (83)
Life-Years Gained From Defibrillator Implantation: Markedly Nonlinear Increase During 3 Years of Follow-Up and Its Implications (2004) (81)
Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long‐Term Registry (2018) (80)
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Part II: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications. (2006) (78)
Skeletal Muscle Reflex in Heart Failure Patients: Role of Hydrogen (2003) (77)
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. (2016) (76)
Autonomic control of the heart and peripheral vessels in human septic shock (1995) (76)
Load dependence of changes in forearm and peripheral vascular resistance after acute leg exercise in man. (1994) (76)
Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2018) (75)
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long‐term comparison (2017) (74)
Challenges in secondary prevention after acute myocardial infarction: A call for action (2016) (74)
Cardiovascular and ventilatory control during exercise in chronic heart failure: role of muscle reflexes. (2008) (73)
Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones (2014) (73)
Cardiothoracic ratio from postero-anterior chest radiographs: a simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease. (2013) (73)
Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification (2000) (73)
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients. (2009) (72)
Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure. (1996) (72)
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups (2013) (72)
Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role (2014) (71)
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. (2008) (71)
Ventilatory response to exercise correlates with impaired heart rate variability in patients with chronic congestive heart failure. (1998) (70)
Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (2004) (70)
Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure (2020) (69)
Telerehabilitation in heart failure patients: The evidence and the pitfalls. (2016) (68)
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry (2020) (67)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (65)
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study) (2010) (65)
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group (2016) (65)
Aerobic exercise physiology in a professional rugby union team. (2003) (64)
ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients (2015) (64)
Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias (2017) (63)
Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study. (1999) (63)
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw (2011) (63)
Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper (2020) (63)
Pathophysiology of human heart failure: importance of skeletal muscle myopathy and reflexes (2014) (63)
Exercise intolerance in adults with congenital heart disease. (2006) (62)
Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure. (1996) (62)
The 'skeletal muscle hypothesis in heart failure' revised. (2013) (61)
Left Atrial Function Predicts Cardiovascular Events in Patients With Chronic Heart Failure With Reduced Ejection Fraction (2019) (61)
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (61)
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure (2011) (59)
Influence of Arterial Baroreceptors on Heart Rate Variability (1998) (59)
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study (2018) (59)
Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors (1995) (58)
Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF‐Wii study; a multicentre randomized controlled trial (2015) (58)
Aetiology and pathophysiological implications of oscillatory ventilation at rest and during exercise in chronic heart failure. Do Cheyne and Stokes have an important message for modern-day patients with heart failure? (1999) (58)
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure (2013) (58)
Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. (2010) (57)
Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry (2019) (57)
Challenges in secondary prevention after acute myocardial infarction: A call for action (2017) (55)
Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). (2004) (54)
Chemoreceptor dependence of very low frequency rhythms in advanced chronic heart failure. (1997) (53)
Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure. (2002) (52)
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part III: Interpretation of cardiopulmonary exercise testing in chronic heart failure and future applications: Task Force of the Italian Work (2006) (51)
Exercise training in chronic heart failure: mechanisms and therapies (2013) (51)
Chemo- and ergoreflexes in health, disease and ageing. (2005) (50)
Challenges in secondary prevention of cardiovascular diseases: a review of the current practice. (2015) (49)
Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials. (2014) (49)
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. (2004) (48)
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. (2000) (47)
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2021) (47)
Origin of oscillatory kinetics of respiratory gas exchange in chronic heart failure. (1999) (46)
Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension (2012) (45)
Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure: A Putative Role for Prostaglandins in Reflex Ventilatory Control (2002) (45)
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years (2019) (45)
Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure. (1998) (45)
Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure A Putative Role for Prostaglandins in Reflex Ventilatory Control (2002) (44)
Low Serum Ferroxidase I Activity Is Associated With Mortality in Heart Failure and Related to Both Peroxynitrite-Induced Cysteine Oxidation and Tyrosine Nitration of Ceruloplasmin (2014) (44)
Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure: A Meta-Analysis of Randomized Controlled Trials. (2018) (44)
Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut‐off criteria (2014) (44)
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease. (2021) (43)
Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2019) (42)
Exercise training in heart failure (2006) (42)
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. (1999) (41)
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport. (2019) (41)
Determinants of respiratory sinus arrhythmia in the vagotomized rabbit. (1995) (40)
Exercise training reverses exertional oscillatory ventilation in heart failure patients (2012) (40)
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology (2020) (40)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
Effect of altering conditions of the sequence method on baroreflex sensitivity (2001) (39)
Time Course of Effects of Cardiac Resynchronization Therapy in Chronic Heart Failure: Benefits in Patients with Preserved Exercise Capacity (2008) (39)
Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. (1998) (37)
Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías (2018) (37)
Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure (1995) (36)
Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca (2016) (36)
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers (2020) (36)
Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. (2007) (36)
Pulsatility and resistance indices in intrarenal arteries of normal adults (1994) (36)
Time course of haemodynamic changes after maximal exercise (1994) (36)
Challenges in secondary prevention after acute myocardial infarction: A call for action (2017) (35)
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement. (2016) (35)
The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation. (1999) (34)
Reproducibility of heart rate variability measures in patients with chronic heart failure. (1996) (34)
Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure. (2004) (34)
A noninvasive measure of baroreflex sensitivity without blood pressure measurement. (2002) (33)
P-wave dispersion index: a marker of patients with paroxysmal atrial fibrillation. (1997) (33)
The Effect of Baroreceptor Activity on Cardiovascular Regulation (2002) (32)
Postexercise hypotension. (1994) (32)
Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world (2019) (32)
Cardiac rehabilitation in very old patients: data from the Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008)--official report of the Italian Association for Cardiovascular Prevention, Rehabilitation, and Epidemiology. (2010) (32)
Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document (2020) (31)
What constitutes the ‘Minimal Care’ interventions of the nurse, physiotherapist, dietician and psychologist in Cardiovascular Rehabilitation and secondary prevention: A position paper from the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (2018) (31)
OUTSTEP‐HF: randomised controlled trial comparing short‐term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction (2020) (31)
Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology (2016) (31)
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study (2021) (30)
Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST (2013) (30)
Anemia in adults with congenital heart disease relates to adverse outcome. (2009) (30)
Effects of exergaming on exercise capacity in patients with heart failure: results of an international multicentre randomized controlled trial (2020) (30)
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. (2016) (29)
Heart failure and anemia: Effects on prognostic variables. (2017) (29)
Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017) (29)
Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis. (2019) (29)
Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiolog (2020) (29)
Exercise programs for LVAD supported patients: A snapshot from the ESC affiliated countries. (2015) (29)
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry (2020) (28)
The Italian Survey on Cardiac Rehabilitation-2008 (ISYDE-2008). Part 3. National availability and organization of cardiac rehabilitation facilities. Official report of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (IACPR-GICR). (2008) (28)
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation (2015) (28)
Effects of acute vasodilation on the hemodynamic response to muscle metaboreflex. (2013) (28)
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). (2017) (27)
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. (2015) (27)
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid (2020) (27)
Comparison of myocardial deformation and velocity dyssynchrony for identification of responders to cardiac resynchronization therapy (2009) (27)
Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation. (2003) (27)
Atrial Late Potentials in Patients with Paroxysmal Atrial Fibrillation Detected Using a High Gain, Signal‐Averaged Esophageal Lead (1994) (27)
Role of gender, age and BMI in prognosis of heart failure (2020) (27)
Very-low-frequency oscillations in heart rate and blood pressure in periodic breathing: role of the cardiovascular limb of the hypoxic chemoreflex. (2000) (27)
Heart rhythms, ventricular arrhythmias, and death in chronic heart failure. (1996) (27)
Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS) (2018) (26)
Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database (2017) (26)
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study (2020) (25)
Physical Exercise for Late-Life Depression: Effects on Heart Rate Variability. (2016) (25)
Exercise training for chronic heart failure (ExTraMATCH II): protocol for an individual participant data meta-analysis. (2014) (24)
COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology (2021) (24)
Cardiovascular risk profile in Olympic athletes: an unexpected and underestimated risk scenario (2018) (24)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) (24)
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. (2013) (24)
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study (2021) (23)
Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure (2003) (23)
Effects of mild physical activity, atenolol and the combination on ambulatory blood pressure in hypertensive subjects (1992) (23)
Upright Cheyne-Stokes Respiration in Patients With Heart Failure. (2020) (23)
Can level of education, accreditation and use of databases in cardiac rehabilitation be improved? Results from the European Cardiac Rehabilitation Inventory Survey (2012) (22)
Impact of periodic breathing on measurement of oxygen uptake and respiratory exchange ratio during cardiopulmonary exercise testing. (2002) (21)
Hemodynamic response to muscle reflex is abnormal in patients with heart failure with preserved ejection fraction. (2017) (21)
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry (2021) (21)
Lifestyle modification in secondary prevention (2017) (21)
Incidence of atrial fibrillation in an Italian population followed by their GPs through a telecardiology service. (2005) (21)
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients. (1996) (21)
Excessive ventilation during early phase of exercise: A new predictor of poor long‐term outcome in patients with chronic heart failure (2007) (21)
The prognostic value of serial troponin measurements in patients admitted for COVID‐19 (2021) (21)
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease (2017) (21)
Contribution of the Lung to the Genesis of Cheyne‐Stokes Respiration in Heart Failure: Plant Gain Beyond Chemoreflex Gain and Circulation Time (2019) (21)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
Exercise training in heart failure: effect on morbidity and mortality. (2000) (20)
Multidisciplinary and multisetting team management programme in heart failure patients affects hospitalisation and costing. (2006) (20)
Resting Lung Function in the Assessment of the Exercise Capacity in Patients With Chronic Heart Failure (2010) (20)
Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation (2018) (20)
‘heartfailurematters.org’, an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions (2017) (20)
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure--Application of Metabolic Exercise Cardiac Kidney Indexes Score. (2015) (20)
Improvement in aerobic capacity during cardiac rehabilitation in coronary artery disease patients: Is there a role for autonomic adaptations? (2017) (19)
Cardiac Prevention and Rehabilitation "3.0": From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR). (2018) (19)
Arterial baroreceptors as determinants of 0.1hz and respiration-related changes in blood pressure and heart rate spectra (1997) (19)
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias. (2016) (18)
Type 2 diabetes increases the long‐term risk of heart failure and mortality in patients with atrial fibrillation (2019) (18)
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction (2020) (18)
Treatment of chronic heart failure: an expert system advisor for general practitioners. (1990) (18)
[Autonomic nervous system adaptation during physical exercise]. (2001) (17)
Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis (2005) (17)
Frequency-dependent baroreflex control of blood pressure and heart rate during physical exercise. (2006) (17)
Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification. (2007) (17)
Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de las enfermedades del pericardio (2015) (16)
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group. (2015) (16)
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches. (2016) (16)
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group. (2019) (16)
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology (2022) (16)
Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014 (2015) (16)
Exercise training in heart failure (2005) (15)
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era (2020) (15)
Age-related reflex responses from peripheral and central chemoreceptors in healthy men (2014) (15)
Anaerobic Threshold and Respiratory Compensation Point Identification During Cardiopulmonary Exercise Tests in Chronic Heart Failure. (2019) (15)
New Insights in the Diagnosis and Treatment of Heart Failure (2015) (15)
Predicting outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia. (2021) (15)
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction (2019) (14)
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry. (2021) (14)
Indexed maximal left atrial volume predicts response to cardiac resynchronization therapy. (2013) (14)
[Takotsubo syndrome during SARS-CoV-2 pneumonia: a possible cardiovascular complication]. (2020) (14)
Exercise Tolerance Measurements in Pulmonary Vascular Diseases and Chronic Heart Failure (2009) (14)
Myeloperoxidase-Related Chlorination Activity Is Positively Associated with Circulating Ceruloplasmin in Chronic Heart Failure Patients: Relationship with Neurohormonal, Inflammatory, and Nutritional Parameters (2015) (14)
A Machine Learning Approach for Mortality Prediction in COVID-19 Pneumonia: Development and Evaluation of the Piacenza Score (2021) (14)
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease (2021) (13)
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (13)
Regional differences in exercise training implementation in heart failure: findings from the Exercise Training in Heart Failure (ExTraHF) survey (2019) (13)
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa (2016) (13)
Validation of a treadmill exercise test protocol with improved metabolic plateau formation in patients with chronic congestive heart failure. (2001) (13)
[The walking test: use in clinical practice]. (2009) (13)
Regular physical activity only associated with low sedentary time increases survival in post myocardial infarction patient (2019) (13)
Measuring physical activity with activity monitors in patients with heart failure: from literature to practice. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology (2020) (12)
Secondary prevention: Where we are (2017) (12)
Effects of Class III drugs on atrial fibrillation. (1998) (12)
Isocapnic buffering period: From physiology to clinics (2019) (12)
Ventricular assist device patients on the horizon of cardiovascular prevention and rehabilitation. Can we convert challenges into opportunities? (2012) (12)
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure. (1995) (12)
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. (2018) (12)
Cardiopulmonary Exercise Testing in Patients with Heart Failure with Specific Comorbidities (2017) (12)
PREAMI: Perindopril and remodelling in elderly with acute myocardial infarction: Study rationale and design (2000) (11)
Determining the best percent-predicted equation for estimated VO2 peak by a 1-km moderate perceptually-regulated treadmill walk to predict mortality in outpatients with cardiovascular disease. (2017) (11)
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology (2022) (11)
Combined aerobic/resistance/inspiratory muscle training as the 'optimum' exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial. (2020) (11)
Mineralocorticoid receptor antagonists for heart failure: a real‐life observational study (2018) (10)
Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs. (2017) (10)
Effect of cardiac resynchronization therapy on left atrial reverse remodeling: role of echocardiographic AV delay optimization. (2013) (10)
Monitoring functional capacity in heart failure (2019) (10)
Exercise intolerance in patients with chronic heart failure. (1995) (10)
Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (10)
Guidance on the management of left ventricular assist device (LVAD) supported patients for the non‐LVAD specialist healthcare provider: executive summary (2021) (10)
New prospects for PCSK9 inhibition? (2018) (10)
EAPC Core Curriculum for Preventive Cardiology (compare to ESC Core Curriculum for the Cardiologist). (2021) (10)
Attenuated autonomic function in multiple organ dysfunction syndrome across three age groups (2006) (10)
Transplantation of progenitor cells and regeneration of damaged myocardium: more facts or doubts? Insights from experimental and clinical studies (2009) (10)
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) (2022) (10)
Future perspectives in cardiac rehabilitation: a new European Association for Cardiovascular Prevention and Rehabilitation Position Paper on ‘secondary prevention through cardiac rehabilitation’ (2007) (10)
Clinical characteristics and course of patients with diabetes entering cardiac rehabilitation. (2015) (9)
Management of oral chronic pharmacotherapy in patients hospitalized for acute decompensated heart failure. (2014) (9)
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure. (2015) (9)
[The efficacy of oral treatment with flecainide for paroxysmal atrial fibrillation: correlation with plasma concentration]. (1990) (9)
Out-of-hospital early defibrillation successfully challenges sudden cardiac arrest: the Piacenza Progetto Vita project. (2002) (9)
Obesity in heart failure: is it time to rethink the paradox? (2017) (8)
[Standards and outcome measures in cardiovascular rehabilitation. Position paper GICR/IACPR]. (2012) (8)
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure. (1995) (8)
Factors which alter the relationship between ventilation and carbon dioxide production during exercise in normal subjects (2004) (8)
Abnormal temporal dynamics of blood pressure and RR interval regulation in patients with chronic heart failure: relationship to baroreflex sensitivity. (2002) (8)
Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. (2017) (8)
Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial. (2013) (8)
HFA of the ESC position paper on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider Part 3: at the hospital and discharge (2021) (8)
Diagnostic and prognostic indicators in chronic heart failure. (1999) (8)
Alveolar-capillary membrane diffusing capacity and its role in the functional capacity of chronic heart failure patients. (1997) (8)
Capture of Atrial Fibrillation Reduces the Atrial Defibrillation Threshold (2002) (8)
Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health within the general population: Recommendations from the EACPR (Part I) Short title: Exercise and PA characteristics in primary prevention (2012) (7)
Autonomic abnormality in chronic heart failure evaluated by heart rate variability. (1996) (7)
Exercise training in heart failure (2006) (7)
Central role of peripheral mechanisms in exercise intolerance in chronic heart failure: the muscle hypothesis. (1998) (7)
Heart rate and blood pressure monitoring in heart failure (2019) (7)
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study (2022) (7)
Rationale and study design of OUTSTEP‐HF: a randomised controlled study to assess the effect of sacubitril/valsartan and enalapril on physical activity measured by accelerometry in patients with heart failure with reduced ejection fraction (2020) (7)
Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiolog (2020) (7)
Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition. (2017) (7)
Official document on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction--recommendations for performance and interpretation. (2007) (7)
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction. (2020) (6)
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease (2017) (6)
Mobile health and implantable cardiac devices: Patients' expectations (2019) (6)
Measuring left ventricular dimensions by conductance catheter in the rabbit. (1990) (6)
A simple lung ultrasound protocol for the screening of COVID-19 pneumonia in the emergency department (2021) (6)
Heart rate turbulence in adults with repaired tetralogy of Fallot. (2009) (6)
Exercise rehabilitation in heart disease: the real "polypill" for primary and secondary prevention. (2005) (6)
Guía ESC 2020 sobre cardiología del deporte y el ejercicio en pacientes con enfermedad cardiovascular (2021) (6)
TEE screening in atrial flutter: a single-centre experience with retrospective validation of a new risk score for the presence of atrial thrombi. (2008) (6)
P337 ExTraMATCH: exercise training meta analysis of trials in chronic heart failure patients. Reduction in mortality and hospitalization (2003) (6)
Impact analysis of heart failure across European countries: an ESC‐HFA position paper (2022) (6)
Clinician approach to cardiopulmonary exercise testing for exercise prescription in patients at risk of and with cardiovascular disease (2022) (6)
Cardiac Pacing in Unilateral Left Superior Vena Cava: Evaluation by Digital Angiography (1991) (6)
The bottleneck of cardiac rehabilitation for patients with coronary artery disease: How to overcome (2018) (6)
The importance of rehabilitation in the secondary prevention of cardiovascular disease (2018) (6)
876-6 Exercise training meta-analysis of trials in chronic heart failure patients (ExTraMATCH) (2004) (6)
"Rehabilitation" after PCI: nonsense or the only way to achieve lasting results? (2010) (5)
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA). (2021) (5)
Pediatric athletes' ECG and diagnostic performance of contemporary ECG interpretation criteria. (2021) (5)
The complementary role of drug, ablation and device in the electrical therapy of atrial fibrillation (2001) (5)
Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device‐supported patients for the non‐left ventricular assist device specialist healthcare provider: Part 2: at the emergency department (2021) (5)
Corrigendum to ‘Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology’ [Eur J Heart Fail 2018;20:3–15] (2018) (5)
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19 (2021) (5)
1154-98 Ventricular fibrillation triggered by thoracic compression during out-of-hospital cardiac arrest resuscitation in the placenza vita project (2004) (5)
European Journal of Preventive Cardiology. (2019) (5)
CARDIOVASCULAR DEATH RISK IN RECOVERED MID-RANGE EJECTION FRACTION HEART FAILURE: INSIGHTS FROM CARDIOPULMONARY EXERCISE TEST. (2020) (4)
Nordic Walking May Safely Increase the Intensity of Exercise Training in Healthy Subjects and in Patients with Chronic Heart Failure. (2016) (4)
Heart failure: an update from the last years and a look at the near future (2022) (4)
[Cardiac rehabilitation "3.0": from the acute to the chronic stage. A position paper from the Italian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)]. (2018) (4)
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance. (2014) (4)
Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure (2020) (4)
Refining the role of left atrial strain in heart failure with reduced ejection fraction. (2021) (4)
Cardiac regeneration by progenitor cells: what is it known as and what is it still to be known as? (2009) (4)
Editor’s presentation: Staying healthy and fighting cardiovascular disease at the time of COVID (2020) (4)
Anticoagulation in atrial fibrillation: what is certain and what is to come (2003) (4)
HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non‐hospital settings in the community (2021) (4)
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. (2004) (4)
OLD AND NEW EQUATIONS FOR MAXIMAL HEART RATE PREDICTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION ON BETA-BLOCKERS TREATMENT. RESULTS FROM THE MECKI SCORE DATASET. (2022) (4)
Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD) (2020) (4)
Congestive Heart Failure: Stable Chronic Heart Failure Patients (2010) (4)
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan (2022) (4)
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter‐defibrillator for primary prevention? (2022) (4)
Passive bilateral leg cycling with concomitant regional circulatory occlusion for testing mechanoreflex–metaboreflex interactions in humans (2020) (4)
Alternatives to Transplantation in the Treatment of Heart Failure: New Diagnostic and Therapeutic Insights (2015) (3)
Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern. (2003) (3)
Early defibrillation training courses for lay volunteers without cardiopulmonary resuscitation education: the piacenza progetto vita experience (2002) (3)
Levels of evidence in the European Society of Cardiology Guidelines: Gaps in knowledge? (2019) (3)
[Telecardiology: perspectives and limitations]. (2004) (3)
ESC/HFA Quality of Care Centres: the ultimate frontier in unifying heart failure management. (2021) (3)
Chronic heart failure: a multisystem syndrome. (1996) (3)
Exercise training for chronic heart failure (ExTraMATCH II): Why all data are not equal (2018) (3)
Blood pressure changes after upright exercise in normals: evaluation of the role of the autonomic nervous system (1991) (3)
Focus on atherosclerosis and lipids (2020) (3)
[Hypotension following maximum physical exercise. Evaluation of hemodynamic and humoral mechanisms]. (1993) (3)
Effects of exercise on the autonomic control of the heart: training or overtraining? (1994) (3)
E‐health in self‐care of heart failure patients: promises become reality (2018) (3)
47 Quantified mitral regurgitation and left atrial function in HFrEF: intraplay and outcome implications (2021) (3)
A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the coronavirus outbreak: Take-home messages from the Italian experience (2020) (3)
Exercise in heart failure patients: Why and how should nurses care? (2014) (3)
Clinical Potential of Emerging Antiarrhythmic Agents (1999) (3)
Microcomputer-aided diagnosis in cardiology. An expert system based on clinical and phono-mechanocardiographic data. (1989) (3)
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology. (2021) (2)
Critical evaluation of pharmacodynamic tests for cardiovascular diagnosis: An expert system approach (1990) (2)
Pick your threshold: a comparison among different methods of anaerobic threshold evaluation in heart failure prognostic assessment. (2022) (2)
Editor’s presentation (2019) (2)
Time course of pressure and flow in ascending aorta during ejection. (1991) (2)
Emerging concepts in exercise training in chronic heart failure. (2000) (2)
Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research (2010) (2)
[The Italian SurveY on carDiac rEhabilitation 2008 (ISYDE 2008): study presentation]. (2008) (2)
Corrigendum to “Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm”: A prospective parallel placebo-controlled multicentre study [International Journal of Cardiology 68 (1998) 187–196] (1999) (2)
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study (2022) (2)
Is blood flow restriction resistance training the missing piece in cardiac rehabilitation of frail patients? (2022) (2)
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study (2022) (2)
Beta-blocking in heart failure patients. Balancing the evidence. (2001) (2)
Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology (2022) (2)
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS (2018) (2)
Early Repolarization in Pediatric Athletes: A Dynamic Electrocardiographic Pattern With Benign Prognosis (2021) (2)
Focus on Atherosclerosis and Lipids. (2021) (2)
Biventricular pacing in patients with heart failure and intraventricular conduction delay. (2001) (2)
Editor’s Presentation: ‘Smoking habit and congenital heart defects in offspring’ (2020) (1)
Aftereffects of exercise. (1992) (1)
Confronting the reality of COVID (2020) (1)
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA). (2021) (1)
554 Machine learning for prediction of in-hospital mortality in COVID-19 patients: results from an Italian multicentre study (2021) (1)
We are standing on the shoulders of giants. The European Journal of Preventive Cardiology in the years to come: A salutation from the incoming Editor-in-Chief (2017) (1)
The ergoreflex activity during exercise: Predictor of impaired heart rate variability in chronic heart failure (2000) (1)
Physical activity and leisure-time exercise prescription for sedentary/untrained individuals (2019) (1)
Editor comment: Focus on arterial hypertension and coronary artery disease. (2021) (1)
- 131-Origin of Symptoms in Heart Failure (2003) (1)
[Prognostic value of supraventricular arrhythmias in heart failure]. (2001) (1)
Editors’ presentation: Focus on cardiomyopathy and heart failure (2020) (1)
Immune activation and inflammatory system in chronic heart failure: novel pathophysiological hypotheses generate new therapeutic options (2007) (1)
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base. (2022) (1)
Obituary – Pantaleo Giannuzzi (2016) (1)
[Practical issues for implementing physical activity]. (2010) (1)
Editor’s presentation: Towards a personalised approach in exercise-based cardiovascular rehabilitation: An European Association of Preventive Cardiology (EAPC) call for action (2020) (1)
Extramatch: exercise training meta analysis of trails in chronic heart failure patients: effect of concomitant drug therapy (2006) (1)
Lean ∆issue-∞djusted Peak Oxygen Consumption in Chronic Heart Failure Patients (2003) (1)
Brachial pulse pressure in acute heart failure. Results of the Heart Failure Registry (2019) (1)
The year in cardiology 2016: prevention (2017) (1)
Editor’s Presentation Benefit of healthy lifestyle on cardiovascular risk factor control: Focus on body weight, exercise and sleep quality (2019) (1)
Passive cycling with concomitant circulatory occlusion for testing interactions between the exercise pressor reflex afferent pathways: (re)naissance or déjà vu?—Authors’ response (2020) (1)
POSTEXERCISE HYPOTENSION. RESPONSE (1994) (1)
Last Word: Point:Counterpoint authors respond to commentaries on “Increased mechanoreceptor/metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure” (2007) (1)
[Preliminary analysis of an expert system for bloodless cardiologic diagnosis]. (1988) (1)
Factors associated with lack of improvement in submaximal exercise capacity of patients with heart failure (2021) (1)
[Acute coronary syndrome after insect bites: a systematic review of available literature]. (2021) (1)
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases. (2023) (1)
Editor’s presentation: Overweight carries a higher risk for developing heart failure (2020) (1)
ALLiance for sEcondary PREvention after an acute coronary syndrome. The ALLEPRE trial: A multicenter fully nurse-coordinated intensive intervention program. (2018) (1)
Autologous Bone-Marrow Stem Cell Support in Acute Anterior Myocardial Infarction. (2007) (1)
346 Baroreflex sensitivity and autonomic function in Takotsubo syndrome long after the acute phase (2021) (1)
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry (2023) (1)
Physiological basis of fractual complexity properties of heart failure rate variability in man. (2002) (1)
We are standing on the shoulders of giants. (2017) (1)
[Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series]. (2020) (1)
Contribution of the dynamic phonocardiography to the valvular heart disease diagnosis: an expert system study. (1990) (0)
[Comparison between calibrated apexcardiography and invasive technics in the evaluation of diastole: preliminary data]. (1987) (0)
Editor’s presentation (2019) (0)
[Usefulness, timing and modality of ECG stress testing after myocardial revascularization]. (2018) (0)
BIOMARKERS OF MUSCLE AND HEART DAMAGE IN PATIENTS WITH MITOCHONDRIAL DISEASE (2016) (0)
Muscle Ergoreflex Activity and Autonomic Balance Assessed in the Vertical and Horizontal Body Positions in Young Healthy Men (2017) (0)
Editor’s presentation (2017) (0)
Circadian Patterns of Atrial Fibrillation Onset Mechanism: Can Pacing Be Influential? (2002) (0)
338 Autonomic function and hyper-adrenergic tone despite beta-blockers in chronic coronary syndrome with preserved ejection fraction: prevalence and related factors (2021) (0)
Skeletal Muscle Hypothesis in Heart Failure: Potential Triggers of Ergoreflex Stimulation (2003) (0)
Editor’s Presentation (2019) (0)
Editor’s presentation: Care should never stop, particularly after an invasive procedure (2019) (0)
Difference in prevalence of exertional oscillatory ventilation between healthy subjects and patients with cardiovascular disease. (2020) (0)
Welcome on board! Meet the new EHJ board reviewers. (2021) (0)
A Machine Learning Approach for Mortality Prediction in COVID-19 Pneumonia: Development and Evaluation of the Piacenza Score (Preprint) (0)
Skeletal muscle alterations and exercise intolerance in heart failure with preserved ejection fraction patients: ultrasonography assessment of diaphragm and quadriceps (2022) (0)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. (2022) (0)
Editor’s presentation (2018) (0)
[Role of clinical evaluation and functional testing in the tailored follow-up of chronic heart failure patients]. (2010) (0)
NEWS ON CARDIAC REHABILITATION IN 2018 (2019) (0)
Is arterial baroreflex control of blood pressure and heart period active during physical exercise (1994) (0)
In memoriam: Attilio Maseri (1935-2021). (2021) (0)
Focus on sport cardiology and exercise. (2023) (0)
Editorial (2018) (0)
Il Test del Cammino: Utilizzo nella pratica clinica The Walking Test: Use in clinical practice (2009) (0)
Editor’s Presentation. Secondary prevention: First of all, address the basics (2020) (0)
Editor's presentation (2019) (0)
The Importance of Visceral Feedbacks: Focus on Chemoreceptors (2017) (0)
Editor comments: Focus on sport cardiology. (2021) (0)
348 Muscle ergoreflex contribution to the respiratory control is active during both upper and lower limb exercise in heart failure patients (2003) (0)
Editor’s presentation (2018) (0)
Editor’s presentation (2019) (0)
Promoting Prevention: A Call for Action. (2020) (0)
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-COVID Patients with Normal Spirometry and Unexplained Dyspnoea (2022) (0)
Editors' presentation: focus on pharmacological interventions. (2021) (0)
Editor comment. Focus on Cardiovascular Epidemiology and risk stratification. (2022) (0)
Editorial comments: Focus on cardiovascular risk screening. (2022) (0)
Tireless cardiologists needed for (very) tired patients: The case of heart failure (2018) (0)
Re: Cardiac emergencies. A pocket guide: Nolan J, Greenwood J, Mackintosh A: Butterworth Heinemann. £14.99 ISBN 0 7506 3833 8 (1999) (0)
[A case of Wellens syndrome during the COVID-19 pandemic]. (2021) (0)
Editor’s presentation (2018) (0)
Editor’s presentation (2019) (0)
Cardiovascular Prevention and Rehabilitation patients: a report from the Exercise Physiology Section of the European Association for Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac (2012) (0)
Issue 29.11 focus on biomarkers. (2022) (0)
Introduction (2018) (0)
ERGOREFLEX OVERACTIVITY: A POTENTIAL CAUSE OF EXERCISE LIMITATION AND DYSAUTONOMIA IN PATIENTS WITH MITOCHONDRIAL MYOPATHY (2016) (0)
Editor comment: Focus on cardiovascular prevention. (2021) (0)
Clinical practice guidelines of the ESC on myocardial revascularization, 2014 (2015) (0)
Editorial: Cardiovascular Adjustments and Adaptations to Exercise: From the Athlete to the Patient (2020) (0)
Editor’s Presentation: ‘The forbidden fruits: Fake or reality?’ (2020) (0)
Heart Rate Profile in Chronic Atrial Fibrillation (2007) (0)
Focus on sport cardiology and exercise. (2022) (0)
Editor’s presentation (2018) (0)
Editor’s presentation: Do we really need biomarkers for cardiovascular risk prediction? (2020) (0)
Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652]. (2021) (0)
993-39 P-Signal Averaged ECG in the Evaluation of the Risk of Arrhythmic Recurrence in Patients with Paroxysmal Atrial Fibrillation: A Prospective Study (1995) (0)
Exercise intolerance in heart failure: beyond mitochondrial dysfunction. Letter regarding the article ‘Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?’ (2022) (0)
347 From arterial hypertension to left ventricular hypertrophy and heart failure: role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction (2021) (0)
Exercise training for chronic heart failure (ExTraMATCH II): individual participant data meta-analysis of randomised controlled trials (2019) (0)
Editor’s Presentation: ‘It takes a village to reduce cardiovascular risk’ (2019) (0)
Editor’s presentation (2017) (0)
Editor’s presentation (2018) (0)
Editorial comments. FOCUS ON ISCHAEMIC HEART DISEASE. (2022) (0)
Congenital heart disease Hyponatraemia : a strong predictor of mortality in adults with congenital heart disease (2010) (0)
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database. (2023) (0)
Editor’s presentation (2017) (0)
ESC Congress 2004: highlight on exercise and cardiac rehabilitation (2004) (0)
16-54: Heart failure patient wishes regarding future improvements in cardiac implantable device remote monitoring (2016) (0)
Editor’s presentation (2018) (0)
Editor's Presentation (2017) (0)
Focus on cardiovascular rehabilitation and exercise training (2020) (0)
International Journal of Cardiology: Forewords (2004) (0)
Editorial comments: focus on cardiovascular diseases. (2023) (0)
Editor’s presentation: Modifiers in cardiovascular risk estimation (2020) (0)
Cardiovascular variability is/is not an index of autonomic control of circulation. (2006) (0)
Exercise and sport in the management of cardiovascular diseases (ischaemic heart disease, heart failure, and hypertension) (2018) (0)
Editor’s presentation (2017) (0)
Editor’s presentation (2019) (0)
P4434Cardiovascular risk profile in Olympic athletes: an unexpected and underestimated risk scenario (2018) (0)
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC HFA EORP Heart Failure Long-Term Registry. (2023) (0)
Exercise Training Not Offered to Half of Surveyed European Patients with HF (2014) (0)
697 Heart failure patient improvements in clinical status, hospitalisation and costing by multidisciplinary team management programme (2006) (0)
Editors’ presentation: Focus on short communications in cardiovascular prevention (2020) (0)
WITHDRAWN: Atrial Fibrillation (AF) and Heart Failure (HF): Effect on Exercise Tolerance (2007) (0)
351 Systemic activation of skeletal muscle ergoreceptors is associated with the progression of the syndrome of chronic heart failure (2006) (0)
Atrial fibrillation (AF) and heart failure (HF): Effect on exercise tolerance (2007) (0)
Rehabilitation in post-COVID patients. A single center experience (2021) (0)
Editor’s presentation (2017) (0)
Editor’s Presentation: ‘Preventive Cardiology: Quo vadis?’ (2020) (0)
Antiarrhythmic Drug Therapy Before Electrical Cardioversion of Atrial Fibrillation: Is It Really Useful? (2000) (0)
Editor’s presentation (2018) (0)
Editor comment. Focus on Sport Cardiology and Exercise Prescription. (2022) (0)
In chronic heart failure the ergoreflex activity to exercise is a predictor of impaired heart rate variability (1998) (0)
[Class-1C drugs for oral loading in the cardioversion of paroxysmal atrial fibrillation]. (1998) (0)
Editors' introduction: focus on cardiac arrhythmias. (2021) (0)
Speckle-tracking during dipyridamole stress echocardiography in the detection of myocardial ischemia in patients with suspected coronary artery disease (2020) (0)
P1045 ExTraMATCH: exercise training meta analysis of trails in chronic heart failure patients. Effects on mortality and hospitalization in different subgroups (2003) (0)
Dronedarone for Prevention of Atrial Fibrillation: An Unfulfilled Promise? (2006) (0)
Editorial comments: Focus on lipid, obesity, and eating behaviour. (2023) (0)
[Changes in the cardiac rhythm in ischemic cardiopathy]. (2000) (0)
Editor’s Presentation (2019) (0)
Editors' Introduction: Focus on implementation of cardiovascular prevention in clinical practice. (2021) (0)
β -Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality (2022) (0)
In severe heart failure patients ntermittent low-dose dobutamine infusion does not improve exercise tolerance (2000) (0)
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association ( HFA ) of the ESC (2023) (0)
[Heart failure and iron deficiency]. (2019) (0)
Editorial comments: focus on arterial hypertension and co-morbidities. (2022) (0)
Functional limitation and exercise hyperventilation are associated with oscillatory ventilation on exercise in chronic heart failure (1998) (0)
Editorial comments: Focus on atherosclerosis. (2022) (0)
Editor’s presentation (2019) (0)
345 Blood pressure and autonomic function in essential hypertension: comparative evaluation of 24-hour heart rate variability and blood pressure (2021) (0)
Editor’s presentation (2018) (0)
695 Atrial fibrillation and heart failure: effect on exercise tolerance (2007) (0)
Editor comment: Focus on cardiovascular risk stratification and prevention. (2022) (0)
Editor’s presentation: ‘You say you love your children above all else, and yet you are stealing their future in front of their very eyes’ (2019) (0)
Editorial comments: Focus issue Arterial Hypertension and the 2021 ESC Guidelines on Cardiovascular Prevention. (2022) (0)
Editorial comments. FOCUS ON LIPID AND ATHEROSCLEROSIS. (2022) (0)
Editor’s presentation: ‘Accreditation and certification. A step towards optimising quality’ (2019) (0)
160 Multidisciplinary team in heart failure outpatients at high risk of hospital readmission: benefit of combined hospital and home‐based care (2004) (0)
WITHDRAWN: Cardiopulmonary Exercise Testing (CPET) in the Identification of Candidate for Cardiac Resynchronisation Therapy (CRT) (2007) (0)
Editor comment. Focus on Cardiovascular Rehabilitation and Prevention. (2022) (0)
Treatment of Chronic Heart Failure by Biventricular Pacing: Is It Here to Stay? (2003) (0)
[A simple algorithm for the evaluation of isovolumetric relaxation of the left ventricle]. (1987) (0)
Editor’s Presentation (2018) (0)
Focus on exercise and sport cardiology (2020) (0)
Reproducibility of methods for assesing baroreflex sensitivityin normal control and patients with chronic heart failure (1999) (0)
Editor comment: Focus on diabetes and metabolic disorders. (2021) (0)
[Preventive cardiology: comparisons of European and Italian projects with the Cardiac Units from Emilia Romagna region. A workshop of IACPR/GICR - Emilia Romagna]. (2011) (0)
Editor comment: focus on cardiovascular risk factor control. (2021) (0)
Cardiopulmonary exercise test (2020) (0)
Loaddependence ofchanges inforearm andperipheral vascular resistance after acutelegexercise inman (2011) (0)
Editor’s presentation (2018) (0)
Editor’s presentation: ‘Les liaisones dangerouses. The heart in the time of COVID-19’ (2020) (0)
Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test (2021) (0)
Cardiostin 2002. (2002) (0)
Corrigendum to exercise training for chronic heart failure (ExTraMATCH II): Protocol for an individual participant data meta-analysis Int J Cardiol. 2014 Jul 1;174(3):683-7 (2014) (0)
Exogenous and Endogenous β-Receptor Stimulations Produce Similar Autonomic Tone Changes in Chronic Heart Failure Patients (1993) (0)
Editor’s presentation (2018) (0)
Evaluation of preventive cardiology (2017) (0)
Editor’s presentation (2018) (0)
Periodic breathing in chronic heart failure is associated with severe autonomic impairment and increased peripheral chemosensitivity (1997) (0)
Editorial comment: Focus on clinical cardiology. (2022) (0)
342 Cardiorespiratory fitness and systemic vascular resistance: oxygen pressure as a novel marker of peripheral vascular response during cardiopulmonary exercise testing (2021) (0)
[ESC Congress 2004: Physical exercise in cardiologic rehabilitation: do we really need new evidence and new studies?]. (2004) (0)
The MECKI score initiative: a successful and ongoing story (2020) (0)
Characteristics and quality of included studies (2019) (0)
Editor’s Presentation (2019) (0)
Focus on population science. (2022) (0)
PARTICIPATION IN A CLINICAL TRIAL IS ASSOCIATED WITH LOWER MORTALITY IN PATIENTS WITH HEART FAILURE: OBSERVATIONS FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME OF THE EUROPEAN SOCIETY OF CARDIOLOGY HEART FAILURE LONG-TERM REGISTRY (2023) (0)
Editorial (2018) (0)
Editor comment: Focus on pharmacology and pharmacotherapy. (2022) (0)
Editorial comments: Focus on pharmacological management. (2022) (0)
Editor comments: focus on heart failure and cardiomyopathies. (2021) (0)
Editors' introduction: focus on cardiovascular rehabilitation. (2021) (0)
Editor’s Presentation (2018) (0)
Heart Failure Management,: Edited by Norman Sharpe, Martin Dunitz Ltd. Publishers, September 1999, 288 pages, #65.00 (2000) (0)
A patient with heart failure, who is frail: How does this affect therapeutic decisions? (2023) (0)
erobic Training Decreases -Type Natriuretic Peptide Expression and drenergic Activation in Patients With Heart Failure (2006) (0)
[Arrhythmic complications in patients with heart decompensation: when and how to treat]. (1999) (0)
[Role of heart rehabilitation in failure]. (1999) (0)
Editor’s Presentation (2017) (0)
Editors’ presentation: Focus on diabetes mellitus and diet (2020) (0)
Editor’s presentation: The importance of return to work after a cardiac event (2019) (0)
108 PHEOCHROMOCYTOMA-INDUCED CARDIOGENIC SHOCK: A MULTICENTRE ANALYSIS OF CLINICAL PROFILES, MANAGEMENT AND OUTCOMES (2022) (0)
Do Cheyne and Stokes have an important message for modern‐day patients with heart failure? Yes, they do (2020) (0)
Utility of remote monitoring for implantable device controls in the phase 1 of the first wave of COVID 19 pandemic (2021) (0)
Editors' presentation: Focus on cardiovascular risk estimation and risk factors. (2021) (0)
Editor’s presentation (2017) (0)
353 B-BLOCKERS EFFECTS ACCORDING TO SEX: DO SELECTIVITY AND DOSE EQUALLY MATTER? (2022) (0)
Editor's presentation (2018) (0)
Predicting clinical outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia (2021) (0)
Focus on cardiovascular risk factor control. (2022) (0)
Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes? (2023) (0)
humansduring posthandgrip muscle ischemia in Baroreflex modulation of muscle sympathetic nerve (2015) (0)
[New concepts in the interpretation of the cardiovascular and respiratory response to acute physical exercise. Implications in chronic heart failure]. (2000) (0)
Editor's Presentation (2018) (0)
Editor comment: Focus on cardiovascular risk assessment. (2022) (0)
cardiovascular health in individuals with cardiovascular disease (Part III) Importance of characteristics and modalities of physical activity and exercise in the management of (2012) (0)
453 ExTraMATCH: exercise training meta analysis of trials in chronic heart failure patients. Reduction in mortality and hospitalization (2004) (0)
338 Autonomicfunctionandhyper-adrenergictonedespitebeta-blockersin chroniccoronarysyndromewithpreservedejectionfraction:prevalenceand relatedfactors (2021) (0)
The challenge of risk stratification and prevention in athletes (2019) (0)
Letters to the Editor (0)
Editor comment: Focus on heart failure. (2021) (0)
Editor’s presentation (2017) (0)
Cardiac rehabilitation: referral and barriers (2020) (0)
Issue Information (2020) (0)
Focus on cardiomyopathy and heart failure (2023) (0)
Editor’s presentation (2018) (0)
Letters to the Editor (0)
Editor comment: Antihypertensive drugs and cancer-more fakes than facts. (2021) (0)
OP91 Individual Participant Data Meta-Analysis Of Exercise Rehabilitation In Heart Failure (2018) (0)
A year in heart failure: updates of clinical and preclinical findings. (2023) (0)
Editors' presentation: focus on cardiovascular risk assessment. (2021) (0)
459 Cardiac study. effect of autologous intracoronary mononuclear bone marrow cell transplantation in humans in patients after acute anterior myocardial infarction with left ventricular dysfunction (2008) (0)
Oscillatory ventilation during exercise: A marker of functional limitation in chronic heart failure (2000) (0)
Editor comment: Focus on atherosclerosis and lipid. (2022) (0)
Editorial Comments. Focus On Cardiac Rehabilitation and Prevention. (2023) (0)
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population). (2022) (0)
Editor’s presentation: Physical activity intensity in coronary patients: Vigorous is better than light, but light is better than nothing (2020) (0)
“Pill in the Pocket”: How Effective and Safe is this Strategy for Treatment of Recurrences of Atrial Fibrillation? (2004) (0)
Gender and age normalization and ventilation ef ﬁ ciency during exercise in heart failure with reduced ejection fraction (2019) (0)
Cardiac Vagal Tone is Increased after Subarachnoid Haemorrhage (1995) (0)
Effect of moderate exercise training in healthy volunteers. (1999) (0)
Editor’s Presentation (2018) (0)
Editor’s presentation (2017) (0)
Editorial Manager(tm) for European Journal of Cardiovascular Prevention and Rehabilitation Manuscript Draft Manuscript Number: Title: STANDARDS FOR THE USE OF CARDIOPULMONARY EXERCISE TESTING FOR FUNCTIONAL EVALUATION OF CARDIAC PATIENTS A Report from the Exercise Physiology Section of the European (2008) (0)
The European Society of Cardiology Heart Failure Association Annual Congress (2016) (0)
Cardiopulmonary exercise testing in chronic heart failure patients treated with beta-blockers: Still a valid prognostic tool. (2020) (0)
Editor comments: Focus on Cardiac rehabilitation and exercise training. (2021) (0)
Abstract 15154: Objectively Measured Physical Activity in Patients With Heart Failure (2020) (0)
Editor’s presentation: Overweight carries a higher risk for developing heart failure in young women (2020) (0)
45 Cardiac rehabilitation and chronic heart failure (2011) (0)
OP-EUPA210147 1603..1611 (2021) (0)
[Changes in apical cardiac impulse under conditions of acute volume load]. (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Massimo Piepoli?

Massimo Piepoli is affiliated with the following schools:

University of Milan
University of Parma
Imperial College London
University of Oxford
University of Pavia
University of Washington
Sant'Anna School of Advanced Studies

Massimo Piepoli's Academic­Influence.com Rankings

Massimo Piepoli's Degrees

Why Is Massimo Piepoli Influential?

Massimo Piepoli's Published Works

Published Works

What Schools Are Affiliated With Massimo Piepoli?

Massimo Piepoli's AcademicInfluence.com Rankings